'Magic bullet' takes aim at pancreatic cancer

by University of South AustraliaAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainEvery day, more than 1200 people worldwide are told they

Updated on: March 14,2024

'Magic bullet' takes aim at pancreatic cancer

by University of South AustraliaAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainEvery day, more than 1200 people worldwide are told they

Updated on:March 14,2024

Double trouble for triple-negative breast cancer: Two-pronged strategy restores immunotherapy sensitivity

by Kimberly McGhee,Medical University of South CarolinaTumor-fighting immune cells in the tumor before (left) and after (right) combination therapy. After combination therapy, many more tumor-fi

Updated on: September 27,2024

Double trouble for triple-negative breast cancer: Two-pronged strategy restores immunotherapy sensitivity

by Kimberly McGhee,Medical University of South CarolinaTumor-fighting immune cells in the tumor before (left) and after (right) combination therapy. After combination therapy, many more tumor-fi

Updated on:September 27,2024

Team introduces new approach in cancer therapy with innovative mechanism-of-action for ferroptosis induction

byHelmholtz Zentrum MünchenFSP1 condensates in green induced by icFSP1 surrounding a blue nucleus. Credit: Toshitaka NakamuraA team of researchers led by Dr. Marcus Conrad from Helmholtz Munich

Updated on: January 08,2024

Team introduces new approach in cancer therapy with innovative mechanism-of-action for ferroptosis induction

byHelmholtz Zentrum MünchenFSP1 condensates in green induced by icFSP1 surrounding a blue nucleus. Credit: Toshitaka NakamuraA team of researchers led by Dr. Marcus Conrad from Helmholtz Munich

Updated on:January 08,2024

Dual checkpoint inhibitor blockade shows promise as first-line and salvage therapy for Merkel cell carcinoma patients

byH. Lee Moffitt Cancer Center & Research InstituteMicrograph of a lung primary small cell carcinoma, a type of carcinoma. Credit: WikipediaMerkel cell carcinoma is a rare but aggressive for

Updated on: January 04,2024

Dual checkpoint inhibitor blockade shows promise as first-line and salvage therapy for Merkel cell carcinoma patients

byH. Lee Moffitt Cancer Center & Research InstituteMicrograph of a lung primary small cell carcinoma, a type of carcinoma. Credit: WikipediaMerkel cell carcinoma is a rare but aggressive for

Updated on:January 04,2024

Modeling the use of beta radiation in cancer treatment

bySpringerIllustration of beta decay proceeding against the backdrop of a Monte Carlo simulation. Credit: Robert LeaTreating superficial skin tumors especially when they are located above cartil

Updated on: January 02,2024

Modeling the use of beta radiation in cancer treatment

bySpringerIllustration of beta decay proceeding against the backdrop of a Monte Carlo simulation. Credit: Robert LeaTreating superficial skin tumors especially when they are located above cartil

Updated on:January 02,2024

Research suggests natural compound could be promising new alternative treatment for colon cancer

FEBRUARY 26, 2024byUniversity of PortsmouthSchisandrin B inhibits the proliferation of human colon cancer cells. Credit:ACS Pharmacology & Translational Science(2024). DOI: 10.10

Updated on: March 27,2024

Research suggests natural compound could be promising new alternative treatment for colon cancer

FEBRUARY 26, 2024byUniversity of PortsmouthSchisandrin B inhibits the proliferation of human colon cancer cells. Credit:ACS Pharmacology & Translational Science(2024). DOI: 10.10

Updated on:March 27,2024

Is the pap smear on the way out?

by Steven Reinberg, Healthday Reporter(HealthDay)—The Pap test, used for over 50 years to spot the early signs of cervical cancer, may soon become a thing of the past, new research suggests.Its replac

Updated on: April 01,2024

Is the pap smear on the way out?

by Steven Reinberg, Healthday Reporter(HealthDay)—The Pap test, used for over 50 years to spot the early signs of cervical cancer, may soon become a thing of the past, new research suggests.Its replac

Updated on:April 01,2024

Key insights from statistical modeling of cancer patient life expectancy

by Karolinska InstitutetCredit: Pixabay/CC0 Public DomainWith the progress in treatment for most cancer types, there is a growing interest to understand the overall impact of a cancer diagnosis t

Updated on: April 06,2024

Key insights from statistical modeling of cancer patient life expectancy

by Karolinska InstitutetCredit: Pixabay/CC0 Public DomainWith the progress in treatment for most cancer types, there is a growing interest to understand the overall impact of a cancer diagnosis t

Updated on:April 06,2024

Novel drug combination shows promise for advanced HER2-negative breast cancer

by Johns Hopkins University School of MedicineClinical efficacy.a–c, Responses as shown by a waterfall plot (a), swimmers plot (b) and spider plot (c). The dashed lines correspond to +20% a

Updated on: May 09,2024

Novel drug combination shows promise for advanced HER2-negative breast cancer

by Johns Hopkins University School of MedicineClinical efficacy.a–c, Responses as shown by a waterfall plot (a), swimmers plot (b) and spider plot (c). The dashed lines correspond to +20% a

Updated on:May 09,2024

Renal impairment linked to worse prognosis in IgD multiple myeloma

by Elana GotkineFor patients with immunoglobulin D multiple myeloma (IgD MM), those with renal impairment (RI) have poorer prognosis and shorter median survival than those with no renal impairment (no

Updated on: January 04,2024

Renal impairment linked to worse prognosis in IgD multiple myeloma

by Elana GotkineFor patients with immunoglobulin D multiple myeloma (IgD MM), those with renal impairment (RI) have poorer prognosis and shorter median survival than those with no renal impairment (no

Updated on:January 04,2024

New microfluidic device shows tumor shape predicts cancer aggressiveness

byUniversity of TorontoThe image shows culture, release and transfer of the tumoroids from the ReSCUE platform, as well as the released breast cancer disk-, rod-, and U-shaped tumoroids cultured

Updated on: December 02,2024

New microfluidic device shows tumor shape predicts cancer aggressiveness

byUniversity of TorontoThe image shows culture, release and transfer of the tumoroids from the ReSCUE platform, as well as the released breast cancer disk-, rod-, and U-shaped tumoroids cultured

Updated on:December 02,2024

Combining targeted therapy and immunotherapy improves overall survival in patients with anaplastic thyroid cancer

byUniversity of Texas M. D. Anderson Cancer CenterOncoprint of targeted somatic gene variants of tumors in patients with anaplastic thyroid cancer (atc) enrolled in cohorts 1 to 3. Credit:

Updated on: November 11,2024

Combining targeted therapy and immunotherapy improves overall survival in patients with anaplastic thyroid cancer

byUniversity of Texas M. D. Anderson Cancer CenterOncoprint of targeted somatic gene variants of tumors in patients with anaplastic thyroid cancer (atc) enrolled in cohorts 1 to 3. Credit:

Updated on:November 11,2024